Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
- PMID: 16398746
- DOI: 10.1111/j.1537-2995.2006.00687.x
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
Similar articles
-
Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients.Transfusion. 2003 Mar;43(3):415-6. doi: 10.1046/j.1537-2995.2003.00336.x. Transfusion. 2003. PMID: 12675731 No abstract available.
-
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014.Transfusion. 2014 Dec;54(12):3257-9. doi: 10.1111/trf.12917. Transfusion. 2014. PMID: 25496391 No abstract available.
-
Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Arch Intern Med. 1994 May 9;154(9):982-7. Arch Intern Med. 1994. PMID: 8179455
-
[The hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura in adulthood. New aspects in their pathophysiology and therapy].Dtsch Med Wochenschr. 1993 Jan 22;118(3):69-75. doi: 10.1055/s-2008-1059303. Dtsch Med Wochenschr. 1993. PMID: 8425461 Review. German. No abstract available.
-
Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.Semin Thromb Hemost. 1982 Jul;8(3):186-97. doi: 10.1055/s-2007-1005051. Semin Thromb Hemost. 1982. PMID: 6753155 Review. No abstract available.
Cited by
-
Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports.Int J Hematol. 2012 Oct;96(4):506-12. doi: 10.1007/s12185-012-1162-2. Epub 2012 Aug 10. Int J Hematol. 2012. PMID: 22878941
-
Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy.Blood. 2009 Mar 5;113(10):2172-80. doi: 10.1182/blood-2008-08-173021. Epub 2009 Jan 13. Blood. 2009. PMID: 19141866 Free PMC article.
-
AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura.Blood. 2013 May 9;121(19):3825-9, S1-3. doi: 10.1182/blood-2013-02-486779. Epub 2013 Mar 20. Blood. 2013. PMID: 23515928 Free PMC article.
-
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.Blood. 2008 Jul 1;112(1):11-8. doi: 10.1182/blood-2008-02-078170. Blood. 2008. PMID: 18574040 Free PMC article. Review.
-
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study.Bone Marrow Transplant. 2022 Apr;57(4):554-561. doi: 10.1038/s41409-022-01581-1. Epub 2022 Jan 25. Bone Marrow Transplant. 2022. PMID: 35079139
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources